The following antibodies were used for Western blots: anti-calreticulin (Upstate Biotechnology); anti−α-tubulin (Calbiochem); anti-VEGFR1 (Santa Cruz Biotechnology, Inc.); anti-VEGFR2 (Cell Signaling Technologies) and anti-TXA2 receptor α (TXA2R(α); Cayman Chemical). Total protein was prepared by boiling cells for 5 min in 50 mM Tris, pH 6.8, 100 mM DTT, 2% SDS, 0.1% Bromophenol blue, and 10% glycerol (107 cells/ml). Extracts were resolved on SDS polyacrylamide gels, transferred to Immobilon P membranes (Millipore), and analyzed by Western blotting. Proteins were detected by chemiluminescence using ECL-Plus (GE Healthcare).
Gene expression analysis
Total RNA was purified with Trizol (Invitrogen). cDNA was prepared by annealing 1 μg RNA with 250 ng of a 1:5 mixture of random and oligo(dT) primers (Promega) at 68°C for 10 min, followed by incubation with Moloney murine leukemia virus reverse transcriptase (Invitrogen) with 10 mM dithiothreitol, RNasin (Promega), and 0.5 mM dNTPs at 42°C for 1 h. Reactions were diluted to a final volume of 100 μl and subjected to heat-inactivation at 98°C for 10 min. Reactions (25 μl) contained 2.5 μl cDNA, 12.5 μl of SYBR Green Master Mix (Applied Biosystems), and appropriate primers. Product accumulation was monitored by SYBR Green fluorescence. Control reactions lacking reverse transcriptase yielded little or no signals. The relative expression levels were determined from a standard curve of serial dilutions of cDNA samples from untreated control cells, and measurements were conducted under conditions of linearity.
Two-dimensional gel electrophoresis and mass spectrometry
Cells were harvested, washed twice with ice-cold PBS, and lysed in lysis buffer containing 10 mM Tris, pH 7.4, 0.3% SDS, 100 μg/ ml Ribonuclease A (Sigma-Aldrich), 200 μg/ml DNase I (Sigma-Aldrich), 20 μg/ml leupeptin (Sigma-Aldrich), 6 μg/ml E-64 (Sigma-Aldrich), 1 mM EDTA (Calbiochem), and 100 μg/ml benzamidine (Sigma-Aldrich). Cells were incubated on ice for 30 min; an equal volume of loading buffer containing 60 mM Tris, pH 6.8, 5% SDS, and 10% glycerol was added; and samples were boiled for 5 min. Two-dimensional gel electrophoresis was conducted using pH 3.5-10 ampholines, and proteins were detected by Coomassie blue staining. MALDI mass spectrometry was conducted by the Columbia University protein core facility.
Reagent concentrations
IBMX. The IC 50 of IBMX ranges between 2 and 50 μM (Beavo, 1995) . Based on the IC 50 and titrations, 100 μM was used. Forskolin. As the EC 50 of forskolin for activating adenylyl cyclase is 5-10 μM (Seamon et al., 1981) and 10 μM has been used to activate adenylyl cyclase in endothelial cells (Kurtz et al., 1991) , 10 μM was used. 8-Br cAMP. The EC 50 of 8-Br cAMP for PKA activation is <10 μM (Hei et al., 1991) . Based on the EC 50 , published studies using 100 μM to 5 mM in endothelial cells (Belhassen et al., 1996; Sexl et al., 1997; Dormond et al., 2002) , and titrations, 100 μM was used. H-89. Based on published studies in endothelial cells (Habib et al., 1997; Yamagishi et al., 2001; Smith et al., 2006 ) that used concentrations of 10-50 μM, 10 μM was used. U46619. U46619 activates TXA2 receptors in endothelial cells at concentrations of 100 nM to 30 μM (Ashton et al., 1999; Daniel et al., 1999) . Based on these results and titrations, 1 μM was used.
SQ29548. The IC50 of SQ29548 is 60 nM (Ogletree et al., 1985) . In endothelial cells, concentrations from 100 nM to 30 μM are used (Daniel et al., 1999; Ashton, 2004) . Based on these results and titrations, 2 μM was used.
